Study examines multivessel mortality rates

December 29, 2011 in Cardiology

UAlbany Study Examines Multivessel Mortality Rates

Enlarge

A new study led by School of Public Health Distinguished Professor Emeritus Edward Hannan raises concerns about the use of bare metal stents for patients with multivessel disease.

(Medical Xpress) -- A new study led by University at Albany School of Public Health Distinguished Professor Emeritus Edward L. Hannan finds a link between higher mortality rates and incomplete revascularization procedures for patients suffering from multivessel disease.

According to a population-based study published in Circulation: , for patients who receive percutaneous coronary intervention (PCI) with (BMS) -- a commonly used revascularization procedure for patients with coronary artery disease -- incomplete revascularization (IR) is associated with higher mortality risk as late as eight years after treatment.

The team studied 13,016 patients with multivessel who underwent BMS implantation between 1999 and 2000. The researchers discovered that complete revascularization (CR), in which all diseased vessels have been successfully stented, occurred in only 29.2 percent of patients.

Hannan's team examined the eight-year survival rate of patients with IR vs. CR patients. The respective 8-year survival rates were 78.5 percent for IR patients and 80.8 for CR patients, respectively. The risk of death was higher for IR patients.

The study concludes that IR may be associated with a higher risk of mortality during long-term follow-up after coronary stenting with BMS in patients with multivessel disease.

"These findings should be considered in determining how PCI is performed and in selecting the most appropriate means of revascularization, such as PCI or ," said Hannan.

Provided by University at Albany

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Death rates decline for advanced heart failure patients, but outcomes are still not ideal

UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden ...

Cardiology created 1 hour ago | popularity not rated yet | comments 0

Second-generation TAVI device—Lotus Valve—shows good performance in REPRISE II

22 May 2013, Paris, France: The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted in all of the first 60 patients in results from REPRISE II reported at EuroPCR ...

Cardiology created 5 hours ago | popularity not rated yet | comments 0

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created May 22, 2013 | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created May 22, 2013 | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created May 22, 2013 | popularity 5 / 5 (1) | comments 0


When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs

Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers ...

Diabetes' genetic underpinnings can vary based on ethnic background, studies say

Ethnic background plays a surprisingly large role in how diabetes develops on a cellular level, according to two new studies led by researchers at the Stanford University School of Medicine.

Flu vaccine also linked to narcolepsy in adults, study reports

Finnish researchers unveiled new data Thursday to link the Pandemrix flu vaccine to a higher risk of the sleeping disorder narcolepsy in adults.

J&J expects 10-plus new drug applications by 2017

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

Farm bill: Senate rejects GMO labeling amendment

The Senate has overwhelmingly rejected an amendment allowing states to require labeling of genetically modified foods.

Second child contracts polio in Pakistan's Waziristan

A second child has contracted polio in a restive Pakistani tribal region near the Afghan border after the Taliban banned vaccinations there nearly a year ago, a UN official said Thursday.